Health
Johnson & Johnson Vaccine Might Save the Company – Live Trading News
Johnson & Johnson Vaccine Might Save the Company Headline News
US health care giant Johnson & Johnson, beset by recent scandals over talcum powder and the opioid crisis, is poised for a reputational lift with its pathbreaking coronavirus vaccine.
J & J, which has vowed to sell the vaccine at cost, won approval Thursday from the European Union for its Covid-19 jab after receiving the green light earlier from regulators in the United States, Canada and South Africa.
The J & J inoculation is the first approved by health authorities to require just one shot, the…
-
General21 hours agoByford rail extension opening marks final stage of Perth Metronet
-
General23 hours agoMango the muster cat draws attention to western Queensland’s ongoing recovery
-
General14 hours agoAustralia’s Diamonds defeat South Africa’s Proteas 65-42 in third netball Test
-
Business23 hours agoTop brokers name 3 ASX shares to buy next week 12 October 2025